Evidence map›Paper›PMID 29225815›Full record

ArticleClinical kidney journal2017

Hypercalcaemia preceding diagnosis of

Jonathan Ling, Tara Anderson, Sanchia Warren, Geoffrey Kirkland, Matthew Jose, Richard Yu, Steven Yew, Samantha Mcfadyen, Alison Graver, William Johnson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Kidney medicine · 2024
    Article
  2. Article
  3. Development and Validation of a Diagnostic Nomogram forInfection and drug resistance · 2023
    Article
  4. Sero-Epidemiology ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  5. Distinct Clinical and Laboratory Patterns ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  6. BMJ case reports · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jonathan LingDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Tara AndersonDepartment of Infectious Diseases, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Sanchia WarrenDepartment of Infectious Diseases, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Geoffrey KirklandDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Matthew JoseDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Richard YuDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Steven YewDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Samantha McfadyenDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Alison GraverDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
William JohnsonDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Lisa JeffsDepartment of Nephrology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Royal Hobart Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe overall incidence of

methodsWe present a case series of four patients displaying hypercalcaemia with an eventual diagnosis of PJP and document the management of the outbreak with a multidisciplinary team approach. We discuss the underlying pathophysiology and previous reports of hypercalcaemia preceding a diagnosis of PJP. We also reviewed the evidence concerning PJP diagnosis and treatment.

resultsWithin our renal transplant cohort, four patients presented within 7 months with hypercalcaemia followed by an eventual diagnosis of PJP. We measured their corrected calcium, parathyroid hormone (PTH), 1,25-dihydroxycholecalciferol [1,25-(OH)

conclusionsGiven the outbreak of PJP in our renal transplant cohort, and based on previous experience from other units nationally, we implemented cohort-wide prophylaxis with trimethoprim-sulphamethoxazole for 12 months in consultation with our local infectious diseases unit. Within this period there have been no further local cases of PJP.

Indexed as

hypercalcaemiaimmunosuppressionkidney transplantationPneumocystis jiroveciitransplanttrimethoprim-sulphamethoxazole

Identifiers

PMID29225815
PMCPMC5716089
OpenAlexW2701106919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.